SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, M.D., Ph.D., Co-Founder and Chief Executive Officer of Senti, will highlight the Company’s Gene Circuit technology platform, pipeline progress and strategic priorities, with an emphasis on opportunities for partnership across i ...

Netanya, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced the receipt of two new purchase orders from first-response units in two European countries. The first order is a repeat purchase from a police department in Europe. This customer has previously acquired and is actively using the Company’s advanced tactical headset systems and related communic ...

14:15 London, 16:15 Helsinki, 24 February 2026 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) PROFIT WARNING – DECREASE IN EBITDA Stock Exchange Release The Board of Directors of Afarak Group SE (“Company”) estimates that despite higher revenue of 141.3 million Euro, EBITDA for the full year 2025 is at approximately 0.7 million Euro, compared to 2.6 million Euro in 2024.In the Interim financial release H1 2025 published on 15th August 2025, the Company stated the following expectat ...

Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptomsZORYVE® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to treat the itching, redness, and flaking of seborrheic dermatitis anywhere it appears, including hair-bearing areas10 million Americans live with seborrheic dermatitis, a chronic inflammatory skin disease that occurs most often on areas with oil-producing glands, including the face and scalp WEST ...

Keith Hopkins VP, Content Distribution & Marketing for TV One Networks SILVER SPRING, MD., Feb. 24, 2026 (GLOBE NEWSWIRE) -- TV One Networks today announced the appointment of Keith Hopkins as the new Vice President of Content Distribution & Marketing. Hopkins brings two decades of experience spanning content distribution, sports partnerships, and streaming strategy, having held senior leadership roles at Roku, Nexstar Media Group, Pac-12 Conference and NBCUniversal/Comcast. In his new role, Hopkins wil ...

Collaboration powers secure international data sharing through the HiFi Solves Global ConsortiumMENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world’s first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration enables secure international research — allowing genomic insights to travel ac ...

MONTREAL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- On Tuesday, March 10, 2026, Transcontinental Inc. (TSX : TCL.A TCL.B) will hold virtually its Annual and Special Meeting of Shareholders at 2:00 PM. For those who are unable to attend, a recording of the meeting will be accessible as of March 11, 2026, in the “Presentations and events” page of the Investors section of Corporation’s website at www.tc.tc On Tuesday, March 10, 2026, Transcontinental Inc. will also release its first quarter 2026 results. The financial ...

- Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - - First-in-kind technology delivers intra-tumoral alpha-emitting radiotherapeutics, reflects strength of clinical data and strong collaboration with Japanese regulators and clinical societies - JERUSALEM, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that ...

This initiative harnesses the Company’s robust resources, including more than $20 million raised in 2025, to lead advancements in next-generation neural AI ecosystems and the potential acceleration of key AI breakthroughs Yokneam Illit, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, recently announced the launch of ai6 L ...

Core Insights - Resmed is opening a new distribution center in Greenwood, Indiana, set to begin operations in 2027, aimed at expanding its U.S. presence and enhancing distribution capacity across North America [1][2] Group 1: Job Creation and Community Impact - The Greenwood center is expected to create over 100 full-time and contingent jobs in operations, logistics, and management [2] - Resmed is collaborating with local and state partners, including the State of Indiana and the City of Greenwood, to support job creation and advance the project [2][4] Group 2: Operational Efficiency - The new center will serve as a major logistics hub, improving two-day transit coverage across North America from 75% to 90% and reducing delivery times to Canada by one full day [3] - The central location of the Greenwood center will enhance connectivity between coastal operations and support improvements in efficiency, productivity, and delivery speed [3] Group 3: Company Commitment and Vision - Resmed's decision to establish the center in Greenwood reflects its commitment to investing in local communities and enhancing service delivery to patients and providers [4] - The company aims to redefine home healthcare through innovative technologies, empowering individuals to achieve better health outcomes [5]